Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination - A retrospective study of 229 spontaneous bacterial peritonitis episodes

被引:75
作者
Llovet, JM
RodriguezIglesias, P
Moitinho, E
Planas, R
Bataller, R
Navasa, M
Menacho, M
Pardo, A
Castells, A
Cabre, E
Arroyo, V
Gassull, MA
Rodes, J
机构
[1] HOSP GERMANS TRIAS & PUJOL,DEPT GASTROENTEROL,BADEN,SWITZERLAND
[2] HOSP CLIN BARCELONA,LIVER UNIT,BARCELONA,CATALUNYA,SPAIN
关键词
cirrhosis; gram-positive bacteria; selective intestinal decontamination; spontaneous bacterial peritonitis;
D O I
10.1016/S0168-8278(97)80014-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Selective intestinal decontamination with norfloxacin is widely used to prevent spontaneous bacterial infections in cirrhosis. The study was performed to compare the spontaneous bacterial peritonitis occurring in patients with and without prophylactic norfloxacin. Methods: Two hundred and twenty-nine consecutive episodes of spontaneous bacterial peritonitis, (193 in patients without (Group A) and 36 in patients with norfloxacin prophylaxis (Group B)), were retrospectively analyzed. In 100 episodes (86 and 14, respectively), the responsible organism was isolated in ascitic fluid. Results: Clinical and laboratory data at diagnosis were comparable in both groups. There were marked differences (p<0.001) between group A and B in the frequency of peritonitis caused by gram-negative (67.4% vs. 14.3%) and gram-positive (30.2% vs. 78.6%) bacteria. There were three polymicrobial episodes, Bacteria resistant to cefotaxime and gram-negative bacilli resistant to quinolones were isolated in ascitic fluid in nine (seven in Group A and two in Group B) and three episodes (all in Group A), respectively. No differences in the course of infection and patient survival were observed between groups. Conclusions: Spontaneous bacterial peritonitis in patients with and without prophylaxis with norfloxacin are not different in clinical features, response to treatment and prognosis. Spontaneous bacterial peritonitis caused by gram-negative organisms resistant to quinolones is extremely uncommon in patients with cirrhosis receiving prophylactic norfloxacin.
引用
收藏
页码:88 / 95
页数:8
相关论文
共 30 条
[1]   SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS - INCIDENCE, DIAGNOSIS, AND PROGNOSIS [J].
ALMDAL, TP ;
SKINHOJ, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 (03) :295-300
[2]   RISK-FACTORS FOR SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC-PATIENTS WITH ASCITES [J].
ANDREU, M ;
SOLA, R ;
SITGESSERRA, A ;
ALIA, C ;
GALLEN, M ;
VILA, MC ;
COLL, S ;
OLIVER, MI .
GASTROENTEROLOGY, 1993, 104 (04) :1133-1138
[3]   TRANSLOCATION OF CERTAIN INDIGENOUS BACTERIA FROM THE GASTRO-INTESTINAL TRACT TO THE MESENTERIC LYMPH-NODES AND OTHER ORGANS IN A GNOTOBIOTIC MOUSE MODEL [J].
BERG, RD ;
GARLINGTON, AW .
INFECTION AND IMMUNITY, 1979, 23 (02) :403-411
[4]   SYSTEMIC ANTIBIOTIC-THERAPY PREVENTS BACTERIAL-INFECTION IN CIRRHOTIC-PATIENTS WITH GASTROINTESTINAL HEMORRHAGE [J].
BLAISE, M ;
PATERON, D ;
TRINCHET, JC ;
LEVACHER, S ;
BEAUGRAND, M ;
POURRIAT, JL .
HEPATOLOGY, 1994, 20 (01) :34-38
[5]  
DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185
[6]  
DEITCH EA, 1994, GUT, V1, pS23
[7]   RAPID EMERGENCE OF QUINOLONE RESISTANCE IN CIRRHOTIC-PATIENTS TREATED WITH NORFLOXACIN TO PREVENT SPONTANEOUS BACTERIAL PERITONITIS [J].
DUPEYRON, C ;
MANGENEY, N ;
SEDRATI, L ;
CAMPILLO, B ;
FOUET, P ;
LELUAN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (02) :340-344
[8]   CEFOTAXIME IS MORE EFFECTIVE THAN IS AMPICILLIN-TOBRAMYCIN IN CIRRHOTICS WITH SEVERE INFECTIONS [J].
FELISART, J ;
RIMOLA, A ;
ARROYO, V ;
PEREZAYUSO, RM ;
QUINTERO, E ;
GINES, P ;
RODES, J .
HEPATOLOGY, 1985, 5 (03) :457-462
[9]   RENAL IMPAIRMENT AFTER SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS - INCIDENCE, CLINICAL COURSE, PREDICTIVE FACTORS AND PROGNOSIS [J].
FOLLO, A ;
LLOVET, JM ;
NAVASA, M ;
PLANAS, R ;
FORNS, X ;
FRANCITORRA, A ;
RIMOLA, A ;
GASSULL, MA ;
ARROYO, V ;
RODES, J .
HEPATOLOGY, 1994, 20 (06) :1495-1501
[10]  
GARCIATSAO G, 1992, GASTROENTEROL CLIN N, V21, P257